{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:04:07Z","timestamp":1776557047996,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.tjog.2015.12.005","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T10:30:59Z","timestamp":1456569059000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Breast cancer therapy and age difference in cardiovascular disease risks: A population-based cohort study in Taiwan"],"prefix":"10.1016","volume":"55","author":[{"given":"Chen Hui","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Sung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hon-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chieh","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2015.12.005_bib1","unstructured":"Cancer incidence in Taiwan. Department of Health, Executive Yuan, R.O.C. (Taiwan). Available from: http:\/\/www.hpa.gov.tw\/BHPNet\/Web\/Stat\/StatisticsShow.aspx?No=201305060001. [Last Accessed: September 19, 2013]. [In Chinese]"},{"key":"10.1016\/j.tjog.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.6004\/jnccn.2012.0086","article-title":"Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines","volume":"10","author":"Carlson","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.tjog.2015.12.005_bib3","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.1998.16.8.2625","article-title":"Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End-Results Cancer registries","volume":"16","author":"Paszat","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0360-3016(98)00412-X","article-title":"Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada","volume":"43","author":"Paszat","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0360-3016(92)90784-F","article-title":"Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer","volume":"22","author":"Rutqvist","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/bjc.1990.193","article-title":"Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry","volume":"61","author":"Rutqvist","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tjog.2015.12.005_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","article-title":"Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy","volume":"12","author":"Cuzick","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib8","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1200\/JCO.2005.13.755","article-title":"Cardiac morbidity of adjuvant radiotherapy for breast cancer","volume":"23","author":"Patt","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2015.12.005_bib10","first-page":"2965","article-title":"Role of HER2\/neu in tumor progression and therapy","volume":"61","author":"Menard","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tjog.2015.12.005_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12032-010-9593-1","article-title":"Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy","volume":"28","author":"Kalabova","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib12","doi-asserted-by":"crossref","first-page":"e2718","DOI":"10.1136\/bmj.e2718","article-title":"Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women","volume":"344","author":"Kesson","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.tjog.2015.12.005_bib13","doi-asserted-by":"crossref","first-page":"v277","DOI":"10.1093\/annonc\/mdq200","article-title":"Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines","author":"Bovelli","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2010.03.003","article-title":"Cardiac side-effects of cancer chemotherapy","volume":"144","author":"Monsuez","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tjog.2015.12.005_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.tjog.2015.12.005_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMp058315","article-title":"Herceptin and the heart\u2014a molecular modifier of cardiac failure","volume":"354","author":"Chien","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tjog.2015.12.005_bib18","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2006.09.1611","article-title":"Trastuzumab-associated cardiac adverse effects in the Herceptin Adjuvant trial","volume":"25","author":"Suter","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib19","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1200\/JCO.2009.26.0463","article-title":"Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial","volume":"28","author":"Procter","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1200\/JCO.2009.21.9709","volume":"28","author":"Untch","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm0502-459","article-title":"ErbB2 is essential in the prevention of dilated cardiomyopathy","volume":"8","author":"Crone","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.tjog.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80043-4","article-title":"Stress pathways and heart failure","volume":"98","author":"Chien","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tjog.2015.12.005_bib23","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/j.ijrobp.2010.11.036","article-title":"Increased risk of ischemic stroke in young nasopharyngeal carcinoma patients","volume":"81","author":"Lee","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.1997.15.4.1348","article-title":"Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy","volume":"15","author":"Gyenes","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib25","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","article-title":"Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tjog.2015.12.005_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncr.22452","article-title":"Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer","volume":"109","author":"Jagsi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.tjog.2015.12.005_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jnci\/dji067","article-title":"Risk of cardiac death after adjuvant radiotherapy for breast cancer","volume":"97","author":"Giordano","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.tjog.2015.12.005_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(03)00594-7","article-title":"Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy","volume":"57","author":"Woodward","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/cncr.11467","article-title":"Favorable cardiac risk among elderly breast carcinoma survivors","volume":"98","author":"Lamont","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.tjog.2015.12.005_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"6","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib31","first-page":"155","article-title":"Establishment of epithelial cell lines from human and mouse thymus immortalized by the 12S adenoviral E1a gene product","volume":"18","author":"Hibi","year":"1991","journal-title":"Thymus"},{"key":"10.1016\/j.tjog.2015.12.005_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0360-3016(98)00200-4","article-title":"Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer","volume":"42","author":"Das","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tjog.2015.12.005_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","author":"Force","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tjog.2015.12.005_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5114\/aoms.2012.28549","article-title":"Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2\u2014a prospective study","volume":"8","author":"Piotrowski","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.tjog.2015.12.005_bib35","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1161\/circ.104.24.e146","article-title":"Does tamoxifen enhance endothelial function by lowering the plasma levels of homocysteine?","volume":"104","author":"Cattaneo","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.tjog.2015.12.005_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.annonc.a010715","article-title":"The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study","volume":"7","author":"Chang","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tjog.2015.12.005_bib37","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jcem.83.5.4753","article-title":"Effect of tamoxifen on serum lipid metabolism","volume":"83","author":"Hozumi","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.tjog.2015.12.005_bib38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0026-895X(25)09072-8","article-title":"Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa","volume":"41","author":"Boulay","year":"1992","journal-title":"Mol Pharmacol"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455915002892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455915002892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:14:26Z","timestamp":1760897666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455915002892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1028455915002892"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2015.12.005","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer therapy and age difference in cardiovascular disease risks: A population-based cohort study in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}